Skip to main content

Advertisement

SpringerLink
Log in

Autoimmunity in 2016

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The number of peer-reviewed articles published during the 2016 solar year and retrieved using the “autoimmunity” key word remained stable while gaining a minimal edge among the immunology articles. Nonetheless, the quality of the publications has been rising significantly and, importantly, acquisitions have become available through scientific journals dedicated to immunology or autoimmunity. Major discoveries have been made in the fields of systemic lupus erythematosus, rheumatoid arthritis, autoimmunity of the central nervous system, vasculitis, and seronegative spondyloarthrithritides. Selected examples include the role of IL17-related genes and long noncoding RNAs in systemic lupus erythematosus or the effects of anti-pentraxin 3 (PTX3) in the treatment of this paradigmatic autoimmune condition. In the case of rheumatoid arthritis, there have been reports of the role of induced regulatory T cells (iTregs) or fibrocytes and T cell interactions with exciting implications. The large number of studies dealing with neuroimmunology pointed to Th17 cells, CD56(bright) NK cells, and low-level TLR2 ligands as involved in multiple sclerosis, along with a high salt intake or the micriobiome-derived Lipid 654. Lastly, we focused on the rare vasculitides to which numerous studies were devoted and suggested that unsuspected cell populations, including monocytes, mucosal-associated invariant T cells, and innate lymphoid cells, may be crucial to ANCA-associated manifestations. This brief and arbitrary discussion of the findings published in 2016 is representative of a promising background for developments that will enormously impact the work of laboratory scientists and physicians at an exponential rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Selmi C (2010) Autoimmunity in 2009. Autoimmun Rev 9(12):795–800. doi:10.1016/j.autrev.2010.08.008

    Article  CAS  PubMed  Google Scholar 

  2. Selmi C (2011) Autoimmunity in 2010. Autoimmun Rev 10(12):725–732. doi:10.1016/j.autrev.2011.06.004

    Article  CAS  PubMed  Google Scholar 

  3. Selmi C (2012) Autoimmunity in 2011. Clin Rev Allergy Immunol 43(1–2):194–206. doi:10.1007/s12016-012-8330-2

    Article  CAS  PubMed  Google Scholar 

  4. Selmi C (2013) Autoimmunity in 2012. Clin Rev Allergy Immunol 45(2):290–301. doi:10.1007/s12016-013-8386-7

    Article  CAS  PubMed  Google Scholar 

  5. Selmi C (2014) Autoimmunity in 2013. Clin Rev Allergy Immunol 47(1):100–109. doi:10.1007/s12016-014-8426-y

    Article  CAS  PubMed  Google Scholar 

  6. Selmi C (2015) Autoimmunity in 2014. Clin Rev Allergy Immunol 49(2):93–99. doi:10.1007/s12016-015-8504-9

    Article  CAS  PubMed  Google Scholar 

  7. Selmi C (2016) Autoimmunity in 2015. Clin Rev Allergy Immunol 51(1):110–119. doi:10.1007/s12016-016-8576-1

    Article  CAS  PubMed  Google Scholar 

  8. Selmi C (2007) One year in autoimmunity. Autoimmun Rev 7(1):85–93. doi:10.1016/j.autrev.2007.09.001

    Article  CAS  PubMed  Google Scholar 

  9. Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, Garcia-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovsky J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M (2016) Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun Rev 15(10):983–993. doi:10.1016/j.autrev.2016.07.023

    Article  CAS  PubMed  Google Scholar 

  10. Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A (2016) Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 15(5):462–465. doi:10.1016/j.autrev.2016.01.015

    Article  PubMed  Google Scholar 

  11. Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features—a comprehensive review. Clin Rev Allergy Immunol 51(3):293–302. doi:10.1007/s12016-015-8496-5

    Article  PubMed  Google Scholar 

  12. Day J, Otto S, Proudman S, Hayball JD, Limaye V (2017) Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies. Autoimmun Rev 16(1):87–95. doi:10.1016/j.autrev.2016.09.019

    Article  CAS  PubMed  Google Scholar 

  13. Lu X, Tang Q, Lindh M, Dastmalchi M, Alexanderson H, Popovic Silwerfeldt K, Agerberth B, Lundberg IE, Wick C (2017) The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis. J Autoimmun 78:46–56. doi:10.1016/j.jaut.2016.12.003

    Article  CAS  PubMed  Google Scholar 

  14. Bhattarai S, Ghannam K, Krause S, Benveniste O, Marg A, de Bruin G, Xin BT, Overkleeft HS, Spuler S, Stenzel W, Feist E (2016) The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. J Autoimmun 75:118–129. doi:10.1016/j.jaut.2016.08.004

    Article  CAS  PubMed  Google Scholar 

  15. Cherin P, Belizna C, Cartry O, Lascu-Dubos G, de Jaeger C, Delain JC, Crave JC, Hachulla E (2016) Long-term subcutaneous immunoglobulin use in inflammatory myopathies: a retrospective review of 19 cases. Autoimmun Rev 15(3):281–286. doi:10.1016/j.autrev.2015.12.003

    Article  CAS  PubMed  Google Scholar 

  16. Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T (2017) Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. J Autoimmun 77:116–122. doi:10.1016/j.jaut.2016.11.006

    Article  CAS  PubMed  Google Scholar 

  17. Alvarado-Cardenas M, Marin-Sanchez A, Martinez MA, Martinez-Martinez L, Pinal-Fernandez I, Labrador-Horrillo M, Balada E, Mundet-Tuduri X, Gonzalez-Mera L, Casademont J, Acebes EM, Moreno PJ, Juarez C, Grau-Junyent JM, Pujol-Borrell R, Selva-O’Callaghan A (2016) Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev 15(12):1161–1166. doi:10.1016/j.autrev.2016.09.005

    Article  CAS  PubMed  Google Scholar 

  18. Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V (2016) Additional treatments for high-risk obstetric antiphospholipid syndrome: a comprehensive review. Clin Rev Allergy Immunol. doi:10.1007/s12016-016-8571-6

  19. Binder SR, Litwin CM (2016) Anti-phospholipid antibodies and smoking: an overview. Clin Rev Allergy Immunol. doi:10.1007/s12016-016-8565-4

  20. Pengo V, Bison E, Zoppellaro G, Padayattil Jose S, Denas G, Hoxha A, Ruffatti A, Banzato A (2016) APS—diagnostics and challenges for the future. Autoimmun Rev 15(11):1031–1033. doi:10.1016/j.autrev.2016.07.028

    Article  CAS  PubMed  Google Scholar 

  21. Rodriguez-Pinto I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R, Group CRP (2016) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev 15(12):1120–1124. doi:10.1016/j.autrev.2016.09.010

    Article  CAS  PubMed  Google Scholar 

  22. Yelnik CM, Kozora E, Appenzeller S (2016) Cognitive disorders and antiphospholipid antibodies. Autoimmun Rev 15(12):1193–1198. doi:10.1016/j.autrev.2016.09.002

    Article  CAS  PubMed  Google Scholar 

  23. Oku K, Nakamura H, Kono M, Ohmura K, Kato M, Bohgaki T, Horita T, Yasuda S, Amengual O, Atsumi T (2016) Complement and thrombosis in the antiphospholipid syndrome. Autoimmun Rev 15(10):1001–1004. doi:10.1016/j.autrev.2016.07.020

    Article  CAS  PubMed  Google Scholar 

  24. Bertolaccini ML, Contento G, Lennen R, Sanna G, Blower PJ, Ma MT, Sunassee K, Girardi G (2016) Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun 75:30–38. doi:10.1016/j.jaut.2016.04.008

    Article  CAS  PubMed  Google Scholar 

  25. Hoxha A, Banzato A, Ruffatti A, Pengo V (2017) Detection of lupus anticoagulant in the era of direct oral anticoagulants. Autoimmun Rev 16(2):173–178. doi:10.1016/j.autrev.2016.12.010

    Article  CAS  PubMed  Google Scholar 

  26. Sebastiani GD, Iuliano A, Cantarini L, Galeazzi M (2016) Genetic aspects of the antiphospholipid syndrome: an update. Autoimmun Rev 15(5):433–439. doi:10.1016/j.autrev.2016.01.005

    Article  CAS  PubMed  Google Scholar 

  27. Chighizola CB, de Jesus GR, Branch DW (2016) The hidden world of anti-phospholipid antibodies and female infertility: a literature appraisal. Autoimmun Rev 15(6):493–500. doi:10.1016/j.autrev.2016.01.018

    Article  CAS  PubMed  Google Scholar 

  28. Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A (2016) Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature. Autoimmun Rev 15(3):226–235. doi:10.1016/j.autrev.2015.11.009

    Article  CAS  PubMed  Google Scholar 

  29. Simonin L, Pasquier E, Leroyer C, Cornec D, Lemerle J, Bendaoud B, Hillion S, Pers JO, Couturaud F, Renaudineau Y (2016) Lymphocyte disturbances in primary antiphospholipid syndrome and application to venous thromboembolism follow-up. Clin Rev Allergy Immunol. doi:10.1007/s12016-016-8568-1

  30. Mayer-Pickel K, Eberhard K, Lang U, Cervar-Zivkovic M (2016) Pregnancy outcome in women with obstetric and thrombotic antiphospholipid syndrome—a retrospective analysis and a review of additional treatment in pregnancy. Clin Rev Allergy Immunol. doi:10.1007/s12016-016-8569-0

  31. Meroni PL (2016) Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the holy grail we are looking for? J Autoimmun 75:1–5. doi:10.1016/j.jaut.2016.07.003

    Article  CAS  PubMed  Google Scholar 

  32. Moulis G, Audemard-Verger A, Arnaud L, Luxembourger C, Montastruc F, Gaman AM, Svenungsson E, Ruggeri M, Mahevas M, Gerfaud-Valentin M, Brainsky A, Michel M, Godeau B, Lapeyre-Mestre M, Sailler L (2016) Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: a systematic review and meta-analysis. Autoimmun Rev 15(3):203–209. doi:10.1016/j.autrev.2015.11.001

    Article  PubMed  Google Scholar 

  33. Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG (2015) Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. J Autoimmun 65:30–37. doi:10.1016/j.jaut.2015.08.001

    Article  CAS  PubMed  Google Scholar 

  34. Skarstein K, Aqrawi LA, Oijordsbakken G, Jonsson R, Jensen JL (2016) Adipose tissue is prominent in salivary glands of Sjogren’s syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity 49(5):338–346. doi:10.1080/08916934.2016.1183656

    Article  PubMed  Google Scholar 

  35. Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot JM, Chiche L, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Saraux A, Pers JO (2016) Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjogren’s syndrome. J Autoimmun 67:102–110. doi:10.1016/j.jaut.2015.11.002

    Article  CAS  PubMed  Google Scholar 

  36. Konsta OD, Le Dantec C, Charras A, Cornec D, Kapsogeorgou EK, Tzioufas AG, Pers JO, Renaudineau Y (2016) Defective DNA methylation in salivary gland epithelial acini from patients with Sjogren’s syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration. J Autoimmun 68:30–38. doi:10.1016/j.jaut.2015.12.002

    Article  CAS  PubMed  Google Scholar 

  37. Bose T, Diedrichs-Mohring M, Wildner G (2016) Dry eye disease and uveitis: a closer look at immune mechanisms in animal models of two ocular autoimmune diseases. Autoimmun Rev 15(12):1181–1192. doi:10.1016/j.autrev.2016.09.001

    Article  CAS  PubMed  Google Scholar 

  38. Xu C, Wu F, Mao C, Wang X, Zheng T, Bu L, Mou X, Zhou Y, Yuan G, Wang S, Xiao Y (2016) Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease. J Autoimmun 75:50–57. doi:10.1016/j.jaut.2016.07.008

    Article  CAS  PubMed  Google Scholar 

  39. Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Levesque H, Marie I (2017) Interstitial lung disease in primary Sjogren’s syndrome. Autoimmun Rev 16(1):48–54. doi:10.1016/j.autrev.2016.09.017

    Article  CAS  PubMed  Google Scholar 

  40. Szyszko EA, Aqrawi LA, Jonsson R, Brokstad KA, Skarstein K (2016) Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjogren’s syndrome. Autoimmunity 49(1):41–49. doi:10.3109/08916934.2015.1079820

    Article  PubMed  CAS  Google Scholar 

  41. Goules AV, Tzioufas AG (2016) Primary Sjogren’s syndrome: clinical phenotypes, outcome and the development of biomarkers. Autoimmun Rev 15(7):695–703. doi:10.1016/j.autrev.2016.03.004

    Article  CAS  PubMed  Google Scholar 

  42. Barrera MJ, Aguilera S, Castro I, Cortes J, Bahamondes V, Quest AF, Molina C, Gonzalez S, Hermoso M, Urzua U, Leyton C, Gonzalez MJ (2016) Pro-inflammatory cytokines enhance ERAD and ATF6alpha pathway activity in salivary glands of Sjogren’s syndrome patients. J Autoimmun 75:68–81. doi:10.1016/j.jaut.2016.07.006

    Article  CAS  PubMed  Google Scholar 

  43. Uomori K, Nozawa K, Ikeda K, Doe K, Yamada Y, Yamaguchi A, Fujishiro M, Kawasaki M, Morimoto S, Takamori K, Sekigawa I, Chan EK, Takasaki Y (2016) A re-evaluation of anti-NA-14 antibodies in patients with primary Sjogren’s syndrome: significant role of interferon-gamma in the production of autoantibodies against NA-14. Autoimmunity 49(5):347–356. doi:10.1080/08916934.2016.1196676

    Article  CAS  PubMed  Google Scholar 

  44. Fujimura T, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Yoshimoto K, Sakuramoto-Tsuchida S, Yamauchi A, Takeda M, Tsujinaka H, Tanaka Y, Takasawa S (2017) Significance of interleukin-6/STAT pathway for the gene expression of REG Ialpha, a new autoantigen in Sjogren’s syndrome patients, in salivary duct epithelial cells. Clin Rev Allergy Immunol 52(3):351–363. doi:10.1007/s12016-016-8570-7

    Article  CAS  PubMed  Google Scholar 

  45. Masi G, Annunziata P (2016) Sjogren’s syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev 15(5):457–461. doi:10.1016/j.autrev.2016.01.013

    Article  PubMed  Google Scholar 

  46. Espitia-Thibault A, Masseau A, Neel A, Espitia O, Toquet C, Mussini JM, Hamidou M (2017) Sjogren’s syndrome-associated myositis with germinal centre-like structures. Autoimmun Rev 16(2):154–158. doi:10.1016/j.autrev.2016.12.006

    Article  CAS  PubMed  Google Scholar 

  47. Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP (2015) Type I and II interferon signatures in Sjogren’s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren’s related lymphomagenesis. J Autoimmun 63:47–58. doi:10.1016/j.jaut.2015.07.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Haacke EA, Bootsma H, Spijkervet FK, Visser A, Vissink A, Kluin PM, Kroese FG (2017) FcRL4+ B-cells in salivary glands of primary Sjogren’s syndrome patients. J Autoimmun. doi:10.1016/j.jaut.2017.03.012

  49. Chaigne B, Lasfargues G, Marie I, Huttenberger B, Lavigne C, Marchand-Adam S, Maillot F, Diot E (2015) Primary Sjogren’s syndrome and occupational risk factors: a case-control study. J Autoimmun 60:80–85. doi:10.1016/j.jaut.2015.04.004

    Article  PubMed  Google Scholar 

  50. Riemekasten G, Cabral-Marques O (2016) Antibodies against angiotensin II type 1 receptor (AT1R) and endothelin receptor type A (ETAR) in systemic sclerosis (SSc)-response. Autoimmun Rev 15(9):935. doi:10.1016/j.autrev.2016.04.004

    Article  PubMed  Google Scholar 

  51. Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, Goebeler M, Prelog M (2016) Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity 49(8):532–546. doi:10.1080/08916934.2016.1217997

    Article  CAS  PubMed  Google Scholar 

  52. Furnari M, Savarino V, Savarino E (2016) Fecal calprotectin in systemic sclerosis: light and shade of a promising tool. Autoimmun Rev 15(12):1206–1207. doi:10.1016/j.autrev.2016.09.026

    Article  PubMed  Google Scholar 

  53. Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F (2016) Genetic factors and systemic sclerosis. Autoimmun Rev 15(5):427–432. doi:10.1016/j.autrev.2016.01.016

    Article  CAS  PubMed  Google Scholar 

  54. Maria AT, Toupet K, Maumus M, Fonteneau G, Le Quellec A, Jorgensen C, Guilpain P, Noel D (2016) Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J Autoimmun 70:31–39. doi:10.1016/j.jaut.2016.03.013

    Article  CAS  PubMed  Google Scholar 

  55. Furnari M, Savarino V, de Bortoli N, Savarino E (2016) Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants. Autoimmun Rev 15(12):1208–1209. doi:10.1016/j.autrev.2016.09.025

    Article  PubMed  Google Scholar 

  56. Morales-Cardenas A, Perez-Madrid C, Arias L, Ojeda P, Mahecha MP, Rojas-Villarraga A, Carrillo-Bayona JA, Anaya JM (2016) Pulmonary involvement in systemic sclerosis. Autoimmun Rev 15(11):1094–1108. doi:10.1016/j.autrev.2016.07.025

    Article  PubMed  Google Scholar 

  57. Desbois AC, Cacoub P (2016) Systemic sclerosis: an update in 2016. Autoimmun Rev 15(5):417–426. doi:10.1016/j.autrev.2016.01.007

    Article  PubMed  Google Scholar 

  58. Mehta H, Goulet PO, Nguyen V, Perez G, Koenig M, Senecal JL, Sarfati M (2016) Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis. Autoimmunity 49(8):503–513. doi:10.1080/08916934.2016.1230848

    Article  CAS  PubMed  Google Scholar 

  59. Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15(7):690–694. doi:10.1016/j.autrev.2016.03.005

    Article  CAS  PubMed  Google Scholar 

  60. Wallukat G, Muller J, Schimke I (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis: Cabral-Marques O, Riemekasten G., Autoimmun Rev. 2016 Mar 10. Pii: S1568-9972(16)30053-2. Doi: 10.1016/j.autrev.2016.03.005. [Epub ahead of print]. Autoimmun Rev 15(8):856–858. doi:10.1016/j.autrev.2016.04.005

    Article  CAS  PubMed  Google Scholar 

  61. Baranska M, Rychlik-Sych M, Kaszuba A, Dziankowska-Bartkowiak B, Skretkowicz J, Waszczykowska E (2016) Genetic polymorphism of CYP2D6 in patients with systemic lupus erythematosus and systemic sclerosis. Autoimmunity:1–6. doi:10.3109/08916934.2015.1134508

  62. Bossini-Castillo L, Lopez-Isac E, Martin J (2015) Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun 64:53–65. doi:10.1016/j.jaut.2015.07.005

    Article  CAS  PubMed  Google Scholar 

  63. Alves CH, Farrell E, Vis M, Colin EM, Lubberts E (2016) Animal models of bone loss in inflammatory arthritis: from cytokines in the bench to novel treatments for bone loss in the bedside-a comprehensive review. Clin Rev Allergy Immunol 51(1):27–47. doi:10.1007/s12016-015-8522-7

    Article  CAS  PubMed  Google Scholar 

  64. Wu DJ, Gu R, Sarin R, Zavodovskaya R, Chen CP, Christiansen BA, Adamopoulos IE (2016) Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis. J Autoimmun 73:73–84. doi:10.1016/j.jaut.2016.06.004

    Article  CAS  PubMed  Google Scholar 

  65. Baum R, Gravallese EM (2016) Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts. Clin Rev Allergy Immunol 51(1):1–15. doi:10.1007/s12016-015-8515-6

    Article  PubMed  Google Scholar 

  66. Humphrey MB, Nakamura MC (2016) A comprehensive review of immunoreceptor regulation of osteoclasts. Clin Rev Allergy Immunol 51(1):48–58. doi:10.1007/s12016-015-8521-8

    Article  CAS  PubMed  Google Scholar 

  67. Horwood NJ (2016) Macrophage polarization and bone formation: a review. Clin Rev Allergy Immunol 51(1):79–86. doi:10.1007/s12016-015-8519-2

    Article  CAS  PubMed  Google Scholar 

  68. Sabokbar A, Mahoney DJ, Hemingway F, Athanasou NA (2016) Non-canonical (RANKL-independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases. Clin Rev Allergy Immunol 51(1):16–26. doi:10.1007/s12016-015-8523-6

    Article  CAS  PubMed  Google Scholar 

  69. Al Kindi MA, Colella AD, Chataway TK, Jackson MW, Wang JJ, Gordon TP (2016) Secreted autoantibody repertoires in Sjogren’s syndrome and systemic lupus erythematosus: a proteomic approach. Autoimmun Rev 15(4):405–410. doi:10.1016/j.autrev.2016.01.008

    Article  CAS  PubMed  Google Scholar 

  70. Balada E, Selva-O’Callaghan A, Felip L, Ordi-Ros J, Simeon-Aznar CP, Solans-Laque R, Vilardell-Tarres M (2016) Sequence analysis of TMEM173 exon 5 in patients with systemic autoimmune diseases. Autoimmunity 49(1):12–16. doi:10.3109/08916934.2015.1113404

    Article  CAS  PubMed  Google Scholar 

  71. Cruz GI, Shao X, Quach H, Ho KA, Sterba K, Noble JA, Patsopoulos NA, Busch MP, Triulzi DJ, Wong WS, Solomon BD, Niederhuber JE, Criswell LA, Barcellos LF (2016) A child’s HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus. J Autoimmun 74:201–207. doi:10.1016/j.jaut.2016.06.017

    Article  PubMed  Google Scholar 

  72. Dahan S, Shor DB, Comaneshter D, Tekes-Manova D, Shovman O, Amital H, Cohen AD (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15(8):848–853. doi:10.1016/j.autrev.2016.06.003

    Article  PubMed  Google Scholar 

  73. Doria A, Gershwin ME, Selmi C (2016) From old concerns to new advances and personalized medicine in lupus: the end of the tunnel is approaching. J Autoimmun 74:1–5. doi:10.1016/j.jaut.2016.08.007

    Article  PubMed  Google Scholar 

  74. Durcan L, Petri M (2016) Immunomodulators in SLE: clinical evidence and immunologic actions. J Autoimmun 74:73–84. doi:10.1016/j.jaut.2016.06.010

    Article  CAS  PubMed  Google Scholar 

  75. Duron L, Cohen-Aubart F, Diot E, Borie R, Abad S, Richez C, Banse C, Vittecoq O, Saadoun D, Haroche J, Amoura Z (2016) Shrinking lung syndrome associated with systemic lupus erythematosus: a multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes. Autoimmun Rev 15(10):994–1000. doi:10.1016/j.autrev.2016.07.021

    Article  PubMed  Google Scholar 

  76. Floris A, Piga M, Cauli A, Mathieu A (2016) Predictors of flares in systemic lupus erythematosus: preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review. Autoimmun Rev 15(7):656–663. doi:10.1016/j.autrev.2016.02.019

    Article  CAS  PubMed  Google Scholar 

  77. Gatto M, Ghirardello A, Luisetto R, Bassi N, Fedrigo M, Valente M, Valentino S, Del Prete D, Punzi L, Doria A (2016) Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. J Autoimmun 74:208–216. doi:10.1016/j.jaut.2016.07.002

    Article  CAS  PubMed  Google Scholar 

  78. Gatto M, Iaccarino L, Ghirardello A, Punzi L, Doria A (2016) Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: a comprehensive review. J Autoimmun 69:1–11. doi:10.1016/j.jaut.2016.02.003

    Article  CAS  PubMed  Google Scholar 

  79. Gatto M, Saccon F, Zen M, Bettio S, Iaccarino L, Punzi L, Doria A (2016) Success and failure of biological treatment in systemic lupus erythematosus: a critical analysis. J Autoimmun 74:94–105. doi:10.1016/j.jaut.2016.06.014

    Article  PubMed  Google Scholar 

  80. Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, Ceruti S, Trotta F (2016) The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 74:41–72. doi:10.1016/j.jaut.2016.06.013

    Article  CAS  PubMed  Google Scholar 

  81. Hammad A, Mosaad YM, Hammad EM, Elhanbly S, El-Bassiony SR, Al-Harrass MF, Eid R, Sharaf Eldein OA, Alsawah GA, Yahia S, Fawzy IM (2016) Interleukin-17A rs2275913, interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in juvenile lupus and lupus related nephritis. Autoimmunity 49(1):31–40. doi:10.3109/08916934.2015.1101071

    Article  CAS  PubMed  Google Scholar 

  82. Jeltsch-David H, Muller S (2016) Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE. J Autoimmun 74:13–26. doi:10.1016/j.jaut.2016.04.005

    Article  CAS  PubMed  Google Scholar 

  83. Lazzaroni MG, Dall’Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A (2016) A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun 74:106–117. doi:10.1016/j.jaut.2016.06.016

    Article  PubMed  Google Scholar 

  84. Long H, Yin H, Wang L, Gershwin ME, Lu Q (2016) The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun 74:118–138. doi:10.1016/j.jaut.2016.06.020

    Article  CAS  PubMed  Google Scholar 

  85. Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA (2016) Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun 74:182–193. doi:10.1016/j.jaut.2016.06.001

    Article  CAS  PubMed  Google Scholar 

  86. Meroni PL, Penatti AE (2016) Epigenetics and systemic lupus erythematosus: unmet needs. Clin Rev Allergy Immunol 50(3):367–376. doi:10.1007/s12016-015-8497-4

    Article  CAS  PubMed  Google Scholar 

  87. Moroni G, Depetri F, Ponticelli C (2016) Lupus nephritis: when and how often to biopsy and what does it mean? J Autoimmun 74:27–40. doi:10.1016/j.jaut.2016.06.006

    Article  PubMed  Google Scholar 

  88. Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, de Liso F, Grossi C, Meroni PL, Cabiddu G, Messa P, Ravani P, Mosca M (2016) Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun 74:194–200. doi:10.1016/j.jaut.2016.06.012

    Article  PubMed  Google Scholar 

  89. Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, de Liso F, Matinato C, Grossi C, Gatto M, Castellana P, Limardo M, Meroni PL, Messa P, Ravani P, Mosca M (2016) Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun 74:6–12. doi:10.1016/j.jaut.2016.07.010

    Article  PubMed  Google Scholar 

  90. Nielsen CT, Rasmussen NS, Heegaard NH, Jacobsen S (2016) “Kill” the messenger: targeting of cell-derived microparticles in lupus nephritis. Autoimmun Rev 15(7):719–725. doi:10.1016/j.autrev.2016.03.009

    Article  CAS  PubMed  Google Scholar 

  91. Novak GV, Marques M, Balbi V, Gormezano NW, Kozu K, Sakamoto AP, Pereira RM, Terreri MT, Magalhaes CS, Guariento A, Sallum AM, Marini R, Ferriani VP, Barbosa CM, de Castro TC, Ramos VC, Bonfa E, Silva CA (2017) Anti-RO/SSA and anti-La/SSB antibodies: association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus. Autoimmun Rev 16(2):132–135. doi:10.1016/j.autrev.2016.12.004

    Article  CAS  PubMed  Google Scholar 

  92. Paradowska-Gorycka A, Sowinska A, Stypinska B, Grobelna MK, Walczyk M, Olesinska M, Piotrowski P, Jagodzinski PP (2016) Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus. Autoimmunity 49(6):373–382. doi:10.1080/08916934.2016.1196678

    Article  CAS  PubMed  Google Scholar 

  93. Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A (2017) The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 76:10–20. doi:10.1016/j.jaut.2016.10.004

    Article  CAS  PubMed  Google Scholar 

  94. Qian J, Wang Y, Huang C, Yang X, Zhao J, Wang Q, Tian Z, Li M, Zeng X (2016) Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: a PRISMA-compliant systematic review and meta-analysis. Autoimmun Rev 15(3):250–257. doi:10.1016/j.autrev.2015.11.012

    Article  CAS  PubMed  Google Scholar 

  95. Sahebkar A, Rathouska J, Derosa G, Maffioli P, Nachtigal P (2016) Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: a systematic review and meta-analysis of controlled trials. Autoimmun Rev 15(4):344–353. doi:10.1016/j.autrev.2015.12.007

    Article  CAS  PubMed  Google Scholar 

  96. Schneider M (2016) Pitfalls in lupus. Autoimmun Rev 15(11):1089–1093. doi:10.1016/j.autrev.2016.07.033

    Article  CAS  PubMed  Google Scholar 

  97. Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, Ohmura K, Shimamura S, Shida H, Fujieda Y, Kato M, Oku K, Bohgaki T, Horita T, Kusumi I, Atsumi T (2016) Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE. Autoimmun Rev 15(8):786–794. doi:10.1016/j.autrev.2016.03.017

    Article  PubMed  Google Scholar 

  98. Shor DB, Dahan S, Comaneshter D, Cohen AD, Amital H (2016) Does inflammatory bowel disease coexist with systemic lupus erythematosus? Autoimmun Rev 15(11):1034–1037. doi:10.1016/j.autrev.2016.07.027

    Article  PubMed  Google Scholar 

  99. Sin E, Anand P, Frieri M (2016) A link: allergic rhinitis, asthma & systemic lupus erythematosus. Autoimmun Rev 15(5):487–491. doi:10.1016/j.autrev.2016.02.003

    Article  CAS  PubMed  Google Scholar 

  100. Tay SH, Fairhurst AM, Mak A (2017) Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjogren’s syndrome: an updated meta-analysis. Autoimmun Rev 16(2):114–122. doi:10.1016/j.autrev.2016.12.002

    Article  CAS  PubMed  Google Scholar 

  101. Teruel M, Alarcon-Riquelme ME (2016) The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun 74:161–175. doi:10.1016/j.jaut.2016.08.001

    Article  CAS  PubMed  Google Scholar 

  102. Velo-Garcia A, Castro SG, Isenberg DA (2016) The diagnosis and management of the haematologic manifestations of lupus. J Autoimmun 74:139–160. doi:10.1016/j.jaut.2016.07.001

    Article  PubMed  Google Scholar 

  103. Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, Ruiz-Irastorza G (2016) Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev 15(12):1134–1140. doi:10.1016/j.autrev.2016.09.007

    Article  PubMed  Google Scholar 

  104. Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H (2016) Hyperthyroidism association with SLE, lessons from real-life data—a case-control study. Autoimmunity 49(1):17–20. doi:10.3109/08916934.2015.1090985

    Article  PubMed  CAS  Google Scholar 

  105. Watad A, Mahroum N, Whitby A, Gertel S, Comaneshter D, Cohen AD, Amital H (2016) Hypothyroidism among SLE patients: case-control study. Autoimmun Rev 15(5):484–486. doi:10.1016/j.autrev.2016.01.019

    Article  CAS  PubMed  Google Scholar 

  106. Wen J, Stock AD, Chalmers SA, Putterman C (2016) The role of B cells and autoantibodies in neuropsychiatric lupus. Autoimmun Rev 15(9):890–895. doi:10.1016/j.autrev.2016.07.009

    Article  CAS  PubMed  Google Scholar 

  107. Wu H, Zhao M, Tan L, Lu Q (2016) The key culprit in the pathogenesis of systemic lupus erythematosus: aberrant DNA methylation. Autoimmun Rev 15(7):684–689. doi:10.1016/j.autrev.2016.03.002

    Article  CAS  PubMed  Google Scholar 

  108. Zhang F, Wu L, Qian J, Qu B, Xia S, La T, Wu Y, Ma J, Zeng J, Guo Q, Cui Y, Yang W, Huang J, Zhu W, Yao Y, Shen N, Tang Y (2016) Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J Autoimmun 75:96–104. doi:10.1016/j.jaut.2016.07.012

    Article  CAS  PubMed  Google Scholar 

  109. Zhao M, Wang J, Liao W, Li D, Li M, Wu H, Zhang Y, Gershwin ME, Lu Q (2016) Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus. J Autoimmun 69:64–73. doi:10.1016/j.jaut.2016.03.001

    Article  PubMed  CAS  Google Scholar 

  110. Ghodke-Puranik Y, Niewold TB (2015) Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun 64:125–136. doi:10.1016/j.jaut.2015.08.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Chen K, Liu J, Cao X (2017) Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. doi:10.1016/j.jaut.2017.03.008

  112. Figgett WA, Deliyanti D, Fairfax KA, Quah PS, Wilkinson-Berka JL, Mackay F (2015) Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers. J Autoimmun 61:9–16. doi:10.1016/j.jaut.2015.04.007

    Article  CAS  PubMed  Google Scholar 

  113. Coit P, Renauer P, Jeffries MA, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, Sawalha AH (2015) Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun 61:29–35. doi:10.1016/j.jaut.2015.05.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Barreira SC, Fonseca JE (2016) The impact of conventional and biological disease modifying antirheumatic drugs on bone biology. Rheumatoid arthritis as a case study. Clin Rev Allergy Immunol 51(1):100–109. doi:10.1007/s12016-016-8547-6

    Article  CAS  PubMed  Google Scholar 

  115. Cambridge G, Leandro MJ, Lahey LJ, Fairhead T, Robinson WH, Sokolove J (2016) B cell depletion with rituximab in patients with rheumatoid arthritis: multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens. J Autoimmun 70:22–30. doi:10.1016/j.jaut.2016.03.010

    Article  CAS  PubMed  Google Scholar 

  116. Cao H, Lin J, Chen W, Xu G, Sun C (2016) Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review. Autoimmunity 49(8):547–553. doi:10.1080/08916934.2016.1230847

    Article  CAS  PubMed  Google Scholar 

  117. Chan CK, Holroyd CR, Mason A, Zarroug J, Edwards CJ (2016) Are there dangers in biologic dose reduction strategies? Autoimmun Rev 15(7):742–746. doi:10.1016/j.autrev.2016.03.013

    Article  PubMed  Google Scholar 

  118. Chen SY, Hsu WT, Chen YL, Chien CH, Chiang BL (2016) Lymphocyte-activation gene 3(+) (LAG3(+)) forkhead box protein 3(-) (FOXP3(-)) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis. J Autoimmun 68:75–85. doi:10.1016/j.jaut.2016.02.002

    Article  CAS  PubMed  Google Scholar 

  119. Chevalier N, Tan JK, Mason LJ, Robert R, McKenzie CI, Lim F, Wong CH, Macia L, Thorburn AN, Russ BE, Masters SL, Mackay CR (2016) Avenues to autoimmune arthritis triggered by diverse remote inflammatory challenges. J Autoimmun 73:120–129. doi:10.1016/j.jaut.2016.06.018

    Article  CAS  PubMed  Google Scholar 

  120. Clavarino G, Adriouach S, Quesada JL, Clay M, Chevreau M, Trocme C, Grange L, Gaudin P, Gatti E, Pierre P, Cesbron JY, Dumestre-Perard C (2016) Unfolded protein response gene GADD34 is overexpressed in rheumatoid arthritis and related to the presence of circulating anti-citrullinated protein antibodies. Autoimmunity 49(3):172–178. doi:10.3109/08916934.2016.1138220

    Article  CAS  PubMed  Google Scholar 

  121. Conigliaro P, Chimenti MS, Triggianese P, Sunzini F, Novelli L, Perricone C, Perricone R (2016) Autoantibodies in inflammatory arthritis. Autoimmun Rev 15(7):673–683. doi:10.1016/j.autrev.2016.03.003

    Article  CAS  PubMed  Google Scholar 

  122. Dar SA, Haque S, Mandal RK, Singh T, Wahid M, Jawed A, Panda AK, Akhter N, Lohani M, Areeshi MY, Rai G, Datt S, Bhattacharya SN, Ramachandran VG, Das S (2016) Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: a case-control study and meta-analysis. Autoimmunity:1–12. doi:10.1080/08916934.2016.1261833

  123. Elshabrawy HA, Essani AE, Szekanecz Z, Fox DA, Shahrara S (2017) TLRs, future potential therapeutic targets for RA. Autoimmun Rev 16(2):103–113. doi:10.1016/j.autrev.2016.12.003

    Article  CAS  PubMed  Google Scholar 

  124. Fragoulis GE, Fragkioudaki S, Reilly JH, Kerr SC, McInnes IB, Moutsopoulos HM (2016) Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome. J Autoimmun 73:85–91. doi:10.1016/j.jaut.2016.06.008

    Article  CAS  PubMed  Google Scholar 

  125. Galligan CL, Keystone EC, Fish EN (2016) Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritis. J Autoimmun 69:38–50. doi:10.1016/j.jaut.2016.02.008

    Article  CAS  PubMed  Google Scholar 

  126. Houri Levi E, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD, Amital H (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 15(4):393–396. doi:10.1016/j.autrev.2016.01.006

    Article  PubMed  Google Scholar 

  127. Iannone F, Lopalco G, Rigante D, Orlando I, Cantarini L, Lapadula G (2016) Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy. Autoimmun Rev 15(5):447–450. doi:10.1016/j.autrev.2016.01.010

    Article  PubMed  Google Scholar 

  128. Ishikawa LLW, Colavite PM, Fraga-Silva TFC, Mimura LAN, Franca TGD, Zorzella-Pezavento SFG, Chiuso-Minicucci F, Marcolino LD, Penitenti M, Ikoma MRV, Sartori A (2017) Vitamin D deficiency and rheumatoid arthritis. Clin Rev Allergy Immunol 52(3):373–388. doi:10.1007/s12016-016-8577-0

    Article  CAS  PubMed  Google Scholar 

  129. Kalyoncu U, Solmaz D, Emmungil H, Yazici A, Kasifoglu T, Kimyon G, Balkarli A, Bes C, Ozmen M, Alibaz-Oner F, Erten S, Cagatay Y, Cetin GY, Yilmaz S, Yildiz F, Pamuk ON, Kucuksahin O, Kilic L, Yazisiz V, Karadag O, Koca SS, Hayran M, Akar S, Aksu K, Akkoc N, Keser G, Gonullu E, Kisacik B, Onat AM, Soy M, Inanc N, Direskeneli H, Sayarlioglu M, Erken E, Turgay M, Cefle A, Ertenli I, Pay S (2016) Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still’s disease: data from a large multicenter cohort. J Autoimmun 69:59–63. doi:10.1016/j.jaut.2016.02.010

    Article  PubMed  Google Scholar 

  130. Komaki F, Komaki Y, Micic D, Ido A, Sakuraba A (2017) Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-alpha use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun 76:38–52. doi:10.1016/j.jaut.2016.11.004

    Article  PubMed  Google Scholar 

  131. Lazurova I, Tomas L (2017) Cardiac impairment in rheumatoid arthritis and influence of anti-TNFalpha treatment. Clin Rev Allergy Immunol 52(3):323–332. doi:10.1007/s12016-016-8566-3

    Article  CAS  PubMed  Google Scholar 

  132. Li P, Wang X, Zhao MQ, Li LJ, Zhang C, Li BZ, Liu J, Yang XK, Leng RX, Fan YG, Pan HF, Ye DQ (2016) TCR-CD3zeta gene polymorphisms and expression profile in rheumatoid arthritis. Autoimmunity 49(7):466–471. doi:10.1080/08916934.2016.1174855

    Article  CAS  PubMed  Google Scholar 

  133. Lin J, He Y, Chen J, Zeng Z, Yang B, Ou Q (2017) A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6. J Autoimmun 77:67–75. doi:10.1016/j.jaut.2016.10.008

    Article  CAS  PubMed  Google Scholar 

  134. Lopez-Mejias R, Castaneda S, Gonzalez-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martinez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martin J, Gonzalez-Gay MA (2016) Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 15(11):1013–1030. doi:10.1016/j.autrev.2016.07.026

    Article  PubMed  Google Scholar 

  135. Miyashita T, Morimoto S, Fujishiro M, Hayakawa K, Suzuki S, Ikeda K, Miyazawa K, Morioka M, Takamori K, Ogawa H, Sekigawa I, Takasaki Y (2016) Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis. Autoimmunity 49(2):109–114. doi:10.3109/08916934.2015.1113405

    Article  CAS  PubMed  Google Scholar 

  136. Nabi G, Akhter N, Wahid M, Bhatia K, Mandal RK, Dar SA, Jawed A, Haque S (2016) Meta-analysis reveals PTPN22 1858C/T polymorphism confers susceptibility to rheumatoid arthritis in Caucasian but not in Asian population. Autoimmunity 49(3):197–210. doi:10.3109/08916934.2015.1134514

    Article  CAS  PubMed  Google Scholar 

  137. Nevius E, Gomes AC, Pereira JP (2016) Inflammatory cell migration in rheumatoid arthritis: a comprehensive review. Clin Rev Allergy Immunol 51(1):59–78. doi:10.1007/s12016-015-8520-9

    Article  CAS  PubMed  Google Scholar 

  138. Rizzi M, Lorenzetti R, Fischer K, Staniek J, Janowska I, Troilo A, Strohmeier V, Erlacher M, Kunze M, Bannert B, Kyburz D, Voll RE, Venhoff N, Thiel J (2017) Impact of tofacitinib treatment on human B-cells in vitro and in vivo. J Autoimmun 77:55–66. doi:10.1016/j.jaut.2016.10.005

    Article  CAS  PubMed  Google Scholar 

  139. Roark CL, Anderson KM, Aubrey MT, Rosloniec EF, Freed BM (2016) Arthritogenic peptide binding to DRB1*01 alleles correlates with susceptibility to rheumatoid arthritis. J Autoimmun 72:25–32. doi:10.1016/j.jaut.2016.04.006

    Article  CAS  PubMed  Google Scholar 

  140. Seaman A, Darrah E, Infantino M, Meacci F, Manfredi M, Benucci M, Mahler M (2016) Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis. Autoimmun Rev 15(7):776–780. doi:10.1016/j.autrev.2016.03.016

    Article  CAS  PubMed  Google Scholar 

  141. Skalska U, Kontny E (2016) Adipose-derived mesenchymal stem cells from infrapatellar fat pad of patients with rheumatoid arthritis and osteoarthritis have comparable immunomodulatory properties. Autoimmunity 49(2):124–131. doi:10.3109/08916934.2015.1113267

    Article  CAS  PubMed  Google Scholar 

  142. Stofkova A, Krskova K, Vaculin S, Jurcovicova J (2016) Enhanced activity of hormone sensitive lipase (HSL) in mesenteric but not epididymal fat correlates with higher production of epinephrine in mesenteric adipocytes in rat model of cachectic rheumatoid arthritis. Autoimmunity 49(4):268–276. doi:10.3109/08916934.2016.1164145

    Article  CAS  PubMed  Google Scholar 

  143. Wen W, He M, Liang X, Gao SS, Zhou J, Yuan ZY (2016) Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia. Autoimmunity 49(2):115–123. doi:10.3109/08916934.2015.1118761

    Article  CAS  PubMed  Google Scholar 

  144. Messemaker TC, Huizinga TW, Kurreeman F (2015) Immunogenetics of rheumatoid arthritis: understanding functional implications. J Autoimmun 64:74–81. doi:10.1016/j.jaut.2015.07.007

    Article  CAS  PubMed  Google Scholar 

  145. Deng Y, Chang C, Lu Q (2016) The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50(3):377–389. doi:10.1007/s12016-016-8535-x

    Article  CAS  PubMed  Google Scholar 

  146. Karczewski J, Dobrowolska A, Rychlewska-Hanczewska A, Adamski Z (2016) New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity 49(7):435–450. doi:10.3109/08916934.2016.1166214

    Article  CAS  PubMed  Google Scholar 

  147. Marre ML, Profozich JL, Coneybeer JT, Geng X, Bertera S, Ford MJ, Trucco M, Piganelli JD (2016) Inherent ER stress in pancreatic islet beta cells causes self-recognition by autoreactive T cells in type 1 diabetes. J Autoimmun 72:33–46. doi:10.1016/j.jaut.2016.04.009

    Article  CAS  PubMed  Google Scholar 

  148. Pollock RA, Abji F, Gladman DD (2017) Epigenetics of psoriatic disease: a systematic review and critical appraisal. J Autoimmun 78:29–38. doi:10.1016/j.jaut.2016.12.002

    Article  CAS  PubMed  Google Scholar 

  149. Prajzlerova K, Grobelna K, Pavelka K, Senolt L, Filkova M (2016) An update on biomarkers in axial spondyloarthritis. Autoimmun Rev 15(6):501–509. doi:10.1016/j.autrev.2016.02.002

    Article  CAS  PubMed  Google Scholar 

  150. Quaden DH, De Winter LM, Somers V (2016) Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview. Autoimmun Rev 15(8):820–832. doi:10.1016/j.autrev.2016.06.001

    Article  CAS  PubMed  Google Scholar 

  151. Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri SK, Maverakis E (2017) Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun 76:21–37. doi:10.1016/j.jaut.2016.10.009

    Article  PubMed  Google Scholar 

  152. Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Guggino G, Taurog J, Kollnberger S, Ciccia F, Baeten D, Bowness P (2016) Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. J Autoimmun 70:12–21. doi:10.1016/j.jaut.2016.03.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Sakkas LI, Bogdanos DP (2017) Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data. Autoimmun Rev 16(1):10–15. doi:10.1016/j.autrev.2016.09.015

    Article  CAS  PubMed  Google Scholar 

  154. Sgambelluri F, Diani M, Altomare A, Frigerio E, Drago L, Granucci F, Banfi G, Altomare G, Reali E (2016) A role for CCR5(+)CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation. J Autoimmun 70:80–90. doi:10.1016/j.jaut.2016.03.019

    Article  CAS  PubMed  Google Scholar 

  155. Sticherling M (2016) Psoriasis and autoimmunity. Autoimmun Rev 15(12):1167–1170. doi:10.1016/j.autrev.2016.09.004

    Article  CAS  PubMed  Google Scholar 

  156. Sukhov A, Adamopoulos IE, Maverakis E (2016) Interactions of the immune system with skin and bone tissue in psoriatic arthritis: a comprehensive review. Clin Rev Allergy Immunol 51(1):87–99. doi:10.1007/s12016-016-8529-8

    Article  CAS  PubMed  Google Scholar 

  157. Yang ZS, Lin NN, Li L, Li Y (2016) The effect of TNF inhibitors on cardiovascular events in psoriasis and psoriatic arthritis: an updated meta-analysis. Clin Rev Allergy Immunol 51(2):240–247. doi:10.1007/s12016-016-8560-9

    Article  CAS  PubMed  Google Scholar 

  158. Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66–73. doi:10.1016/j.jaut.2015.07.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Isailovic N, Daigo K, Mantovani A, Selmi C (2015) Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun 60:1–11. doi:10.1016/j.jaut.2015.04.006

    Article  CAS  PubMed  Google Scholar 

  160. Aggelakopoulou M, Kourepini E, Paschalidis N, Panoutsakopoulou V (2016) ERbeta in CD4+ T cells is crucial for ligand-mediated suppression of central nervous system autoimmunity. J Immunol 196(12):4947–4956. doi:10.4049/jimmunol.1600246

    Article  CAS  PubMed  Google Scholar 

  161. Aggelakopoulou M, Kourepini E, Paschalidis N, Simoes DC, Kalavrizioti D, Dimisianos N, Papathanasopoulos P, Mouzaki A, Panoutsakopoulou V (2016) ERbeta-dependent direct suppression of human and murine Th17 cells and treatment of established central nervous system autoimmunity by a neurosteroid. J Immunol 197(7):2598–2609. doi:10.4049/jimmunol.1601038

    Article  CAS  PubMed  Google Scholar 

  162. Anstadt EJ, Fujiwara M, Wasko N, Nichols F, Clark RB (2016) TLR tolerance as a treatment for central nervous system autoimmunity. J Immunol 197(6):2110–2118. doi:10.4049/jimmunol.1600876

    Article  CAS  PubMed  Google Scholar 

  163. Aricha R, Reuveni D, Fuchs S, Souroujon MC (2016) Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells. J Autoimmun 67:57–64. doi:10.1016/j.jaut.2015.09.005

    Article  CAS  PubMed  Google Scholar 

  164. Blumenfeld S, Staun-Ram E, Miller A (2016) Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFbeta in patients with multiple sclerosis. J Autoimmun 70:40–51. doi:10.1016/j.jaut.2016.03.012

    Article  CAS  PubMed  Google Scholar 

  165. Chen Q, Liu Y, Lu A, Ni K, Xiang Z, Wen K, Tu W (2017) Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system. J Autoimmun 77:1–10. doi:10.1016/j.jaut.2016.10.006

    Article  PubMed  CAS  Google Scholar 

  166. De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, Conte M, Rosato C, Ciniglio Appiani M, de Vincentiis M (2016) Parkinson’s disease: autoimmunity and neuroinflammation. Autoimmun Rev 15(10):1005–1011. doi:10.1016/j.autrev.2016.07.022

    Article  PubMed  CAS  Google Scholar 

  167. Duraes FV, Lippens C, Steinbach K, Dubrot J, Brighouse D, Bendriss-Vermare N, Issazadeh-Navikas S, Merkler D, Hugues S (2016) pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation. J Autoimmun 67:8–18. doi:10.1016/j.jaut.2015.08.014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  168. Elieh-Ali-Komi D, Cao Y (2017) Role of mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Rev Allergy Immunol 52(3):436–445. doi:10.1007/s12016-016-8595-y

    Article  CAS  PubMed  Google Scholar 

  169. Esposito S, Longo MR (2017) Guillain-Barre syndrome. Autoimmun Rev 16(1):96–101. doi:10.1016/j.autrev.2016.09.022

    Article  PubMed  Google Scholar 

  170. Evangelista MG, Castro SB, Alves CC, Dias AT, Souza VW, Reis LB, Silva LC, Castanon MC, Farias RE, Juliano MA, Ferreira AP (2016) Early IFN-gamma production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 49(4):258–267. doi:10.3109/08916934.2016.1141898

    Article  CAS  PubMed  Google Scholar 

  171. Fraune J, Gerlach S, Rentzsch K, Teegen B, Lederer S, Affeldt K, Fechner K, Danckwardt M, Voigt J, Probst C, Komorowski L, Stocker W (2016) Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM). Autoimmun Rev 15(10):937–942. doi:10.1016/j.autrev.2016.07.024

    Article  PubMed  Google Scholar 

  172. Fraussen J, de Bock L, Somers V (2016) B cells and antibodies in progressive multiple sclerosis: contribution to neurodegeneration and progression. Autoimmun Rev 15(9):896–899. doi:10.1016/j.autrev.2016.07.008

    Article  CAS  PubMed  Google Scholar 

  173. Gao Q, Zhang Y, Han C, Hu X, Zhang H, Xu X, Tian J, Liu Y, Ding Y, Liu J, Wang C, Guo Z, Yang Y, Cao X (2016) Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells. J Autoimmun 69:74–85. doi:10.1016/j.jaut.2016.03.002

    Article  CAS  PubMed  Google Scholar 

  174. Goncalves ED, Souza PS, Lieberknecht V, Fidelis GS, Barbosa RI, Silveira PC, de Pinho RA, Dutra RC (2016) Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Autoimmunity 49(2):132–142. doi:10.3109/08916934.2015.1124425

    Article  CAS  PubMed  Google Scholar 

  175. Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF Jr (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49(7):472–479. doi:10.1080/08916934.2016.1214823

    Article  CAS  PubMed  Google Scholar 

  176. Haggmark-Manberg A, Zandian A, Forsstrom B, Khademi M, Lima Bomfim I, Hellstrom C, Arnheim-Dahlstrom L, Hallbook T, Darin N, Lundberg IE, Uhlen M, Partinen M, Schwenk JM, Olsson T, Nilsson P (2016) Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity 49(6):421–433. doi:10.1080/08916934.2016.1183655

    Article  PubMed  CAS  Google Scholar 

  177. Hucke S, Eschborn M, Liebmann M, Herold M, Freise N, Engbers A, Ehling P, Meuth SG, Roth J, Kuhlmann T, Wiendl H, Klotz L (2016) Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. J Autoimmun 67:90–101. doi:10.1016/j.jaut.2015.11.001

    Article  CAS  PubMed  Google Scholar 

  178. Kok LF, Marsh-Wakefield F, Marshall JE, Gillis C, Halliday GM, Byrne SN (2016) B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack. J Autoimmun 73:10–23. doi:10.1016/j.jaut.2016.05.016

    Article  CAS  PubMed  Google Scholar 

  179. Koneczny I, Stevens JA, De Rosa A, Huda S, Huijbers MG, Saxena A, Maestri M, Lazaridis K, Zisimopoulou P, Tzartos S, Verschuuren J, van der Maarel SM, van Damme P, De Baets MH, Molenaar PC, Vincent A, Ricciardi R, Martinez-Martinez P, Losen M (2017) IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. J Autoimmun 77:104–115. doi:10.1016/j.jaut.2016.11.005

    Article  CAS  PubMed  Google Scholar 

  180. Laroni A, Armentani E, Kerlero de Rosbo N, Ivaldi F, Marcenaro E, Sivori S, Gandhi R, Weiner HL, Moretta A, Mancardi GL, Uccelli A (2016) Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis. J Autoimmun 72:8–18. doi:10.1016/j.jaut.2016.04.003

    Article  CAS  PubMed  Google Scholar 

  181. Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, Mekinian A (2016) Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev 15(12):1129–1133. doi:10.1016/j.autrev.2016.09.008

    Article  CAS  PubMed  Google Scholar 

  182. Lifshitz GV, Zhdanov DD, Lokhonina AV, Eliseeva DD, Lyssuck EY, Zavalishin IA, Bykovskaia SN (2016) Ex vivo expanded regulatory T cells CD4+CD25+FoxP3+CD127Low develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis. Autoimmunity 49(6):388–396. doi:10.1080/08916934.2016.1199020

    Article  CAS  PubMed  Google Scholar 

  183. Lippens C, Duraes FV, Dubrot J, Brighouse D, Lacroix M, Irla M, Aubry-Lachainaye JP, Reith W, Mandl JN, Hugues S (2016) IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun 75:39–49. doi:10.1016/j.jaut.2016.07.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Lucchese G, Kanduc D (2016) Zika virus and autoimmunity: from microcephaly to Guillain-Barre syndrome, and beyond. Autoimmun Rev 15(8):801–808. doi:10.1016/j.autrev.2016.03.020

    Article  CAS  PubMed  Google Scholar 

  185. Milo R (2016) Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmun Rev 15(7):714–718. doi:10.1016/j.autrev.2016.03.006

    Article  CAS  PubMed  Google Scholar 

  186. Montagna G, Imperiali M, Agazzi P, D’Aurizio F, Tozzoli R, Feldt-Rasmussen U, Giovanella L (2016) Hashimoto’s encephalopathy: a rare proteiform disorder. Autoimmun Rev 15(5):466–476. doi:10.1016/j.autrev.2016.01.014

    Article  PubMed  Google Scholar 

  187. Paterka M, Voss JO, Werr J, Reuter E, Franck S, Leuenberger T, Herz J, Radbruch H, Bopp T, Siffrin V, Zipp F (2017) Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis. J Autoimmun 76:108–114. doi:10.1016/j.jaut.2016.09.008

    Article  CAS  PubMed  Google Scholar 

  188. Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15(4):307–324. doi:10.1016/j.autrev.2015.12.004

    Article  CAS  PubMed  Google Scholar 

  189. Rolf L, Damoiseaux J, Hupperts R, Huitinga I, Smolders J (2016) Network of nuclear receptor ligands in multiple sclerosis: common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules. Autoimmun Rev 15(9):900–910. doi:10.1016/j.autrev.2016.07.002

    Article  CAS  PubMed  Google Scholar 

  190. Russi AE, Walker-Caulfield ME, Guo Y, Lucchinetti CF, Brown MA (2016) Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity. J Autoimmun 73:100–110. doi:10.1016/j.jaut.2016.06.015

    Article  CAS  PubMed  Google Scholar 

  191. Selmi C, Barin JG, Rose NR (2016) Current trends in autoimmunity and the nervous system. J Autoimmun 75:20–29. doi:10.1016/j.jaut.2016.08.005

    Article  CAS  PubMed  Google Scholar 

  192. St Charles JL, Bell JA, Gadsden BJ, Malik A, Cooke H, Van de Grift LK, Kim HY, Smith EJ, Mansfield LS (2017) Guillain Barre syndrome is induced in non-obese diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics. J Autoimmun 77:11–38. doi:10.1016/j.jaut.2016.09.003

    Article  CAS  PubMed  Google Scholar 

  193. Teniente-Serra A, Grau-Lopez L, Mansilla MJ, Fernandez-Sanmartin M, Ester Condins A, Ramo-Tello C, Martinez-Caceres E (2016) Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients. Autoimmunity 49(4):219–228. doi:10.3109/08916934.2016.1138271

    Article  CAS  PubMed  Google Scholar 

  194. van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ (2016) From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev 15(10):970–974. doi:10.1016/j.autrev.2016.07.018

    Article  PubMed  CAS  Google Scholar 

  195. Wiwanitkit V (2016) Zika virus, autoimmunity and microcephaly: other things for consideration. Autoimmun Rev 15(8):855. doi:10.1016/j.autrev.2016.04.002

    Article  PubMed  Google Scholar 

  196. Braudeau C, Amouriaux K, Neel A, Herbreteau G, Salabert N, Rimbert M, Martin JC, Hemont C, Hamidou M, Josien R (2016) Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis. J Autoimmun 70:73–79. doi:10.1016/j.jaut.2016.03.015

    Article  CAS  PubMed  Google Scholar 

  197. Brunini F, Page TH, Gallieni M, Pusey CD (2016) The role of monocytes in ANCA-associated vasculitides. Autoimmun Rev 15(11):1046–1053. doi:10.1016/j.autrev.2016.07.031

    Article  CAS  PubMed  Google Scholar 

  198. Chan E, Sangle SR, Coghlan JG, D’Cruz DD (2016) Pulmonary artery aneurysms in Behcet’s disease treated with anti-TNFalpha: a case series and review of the literature. Autoimmun Rev 15(4):375–378. doi:10.1016/j.autrev.2016.01.003

    Article  PubMed  Google Scholar 

  199. Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taille C, Delaval P, Cadranel J, Bonniaud P, Prevot G, Hirschi S, Gondouin A, Dunogue B, Chatte G, Briault C, Pagnoux C, Jayne D, Guillevin L, Cordier JF, Groupe d’Etudes et de Recherche sur les Maladies Orphelines P (2017) Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 16(1):1–9. doi:10.1016/j.autrev.2016.09.018

    Article  CAS  PubMed  Google Scholar 

  200. Criado PR, Marques GF, Morita TC, de Carvalho JF (2016) Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: report of 22 cases and literature review. Autoimmun Rev 15(6):558–563. doi:10.1016/j.autrev.2016.02.010

    Article  PubMed  Google Scholar 

  201. Csernok E, Damoiseaux J, Rasmussen N, Hellmich B, van Paassen P, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X (2016) Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Autoimmun Rev 15(7):736–741. doi:10.1016/j.autrev.2016.03.010

    Article  CAS  PubMed  Google Scholar 

  202. Cui Z, Zhao MH, Jia XY, Wang M, Hu SY, Wang SX, Yu F, Brown KL, Hudson BG, Pedchenko V (2016) Antibodies to alpha5 chain of collagen IV are pathogenic in Goodpasture’s disease. J Autoimmun 70:1–11. doi:10.1016/j.jaut.2016.04.001

    Article  CAS  PubMed  Google Scholar 

  203. De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, Martellucci S, de Vincentiis M (2016) Polyarteritis nodosa: a contemporary overview. Autoimmun Rev 15(6):564–570. doi:10.1016/j.autrev.2016.02.015

    Article  PubMed  Google Scholar 

  204. Espitia O, Samson M, Le Gallou T, Connault J, Landron C, Lavigne C, Belizna C, Magnant J, de Moreuil C, Roblot P, Maillot F, Diot E, Jego P, Durant C, Masseau A, Brisseau JM, Pottier P, Espitia-Thibault A, Santos AD, Perrin F, Artifoni M, Neel A, Graveleau J, Moreau P, Maisonneuve H, Fau G, Serfaty JM, Hamidou M, Agard C (2016) Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients. Autoimmun Rev 15(6):571–576. doi:10.1016/j.autrev.2016.02.016

    Article  PubMed  Google Scholar 

  205. Ferfar Y, Mirault T, Desbois AC, Comarmond C, Messas E, Savey L, Domont F, Cacoub P, Saadoun D (2016) Biotherapies in large vessel vasculitis. Autoimmun Rev 15(6):544–551. doi:10.1016/j.autrev.2016.02.012

    Article  CAS  PubMed  Google Scholar 

  206. Huart A, Josse AG, Chauveau D, Korach JM, Heshmati F, Bauvin E, Cointault O, Kamar N, Ribes D, Pourrat J, Faguer S, French Society of H (2016) Outcomes of patients with Goodpasture syndrome: a nationwide cohort-based study from the French Society of Hemapheresis. J Autoimmun 73:24–29. doi:10.1016/j.jaut.2016.05.015

    Article  PubMed  Google Scholar 

  207. Iannella G, Greco A, Granata G, Manno A, Pasquariello B, Angeletti D, Didona D, Magliulo G (2016) Granulomatosis with polyangiitis and facial palsy: literature review and insight in the autoimmune pathogenesis. Autoimmun Rev 15(7):621–631. doi:10.1016/j.autrev.2016.02.005

    Article  CAS  PubMed  Google Scholar 

  208. Jarrot PA, Kaplanski G (2016) Pathogenesis of ANCA-associated vasculitis: an update. Autoimmun Rev 15(7):704–713. doi:10.1016/j.autrev.2016.03.007

    Article  CAS  PubMed  Google Scholar 

  209. Kerstein A, Schuler S, Cabral-Marques O, Fazio J, Hasler R, Muller A, Pitann S, Moosig F, Klapa S, Haas C, Kabelitz D, Riemekasten G, Wolters S, Lamprecht P (2017) Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis. J Autoimmun 78:79–91. doi:10.1016/j.jaut.2016.12.004

    Article  CAS  PubMed  Google Scholar 

  210. Lefevre G, Ackermann F, Kahn JE (2017) Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome? Autoimmun Rev 16(2):208–209. doi:10.1016/j.autrev.2016.11.001

    Article  PubMed  Google Scholar 

  211. Legendre P, Regent A, Thiebault M, Mouthon L (2017) Anti-endothelial cell antibodies in vasculitis: a systematic review. Autoimmun Rev 16(2):146–153. doi:10.1016/j.autrev.2016.12.012

    Article  CAS  PubMed  Google Scholar 

  212. Lionaki S, Mavragani CP, Karras A, Liapis G, Somarakis G, Boletis JN, Drosos A, Tzioufas AG, Guillevin L, Moutsopoulos HM (2016) Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis. J Autoimmun 72:57–64. doi:10.1016/j.jaut.2016.05.004

    Article  CAS  PubMed  Google Scholar 

  213. Misra DP, Sharma A, Kadhiravan T, Negi VS (2017) A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis. Autoimmun Rev 16(2):179–191. doi:10.1016/j.autrev.2016.12.009

    Article  CAS  PubMed  Google Scholar 

  214. Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, Bellafiore S, Cimino L, Salvarani C (2016) Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis. J Autoimmun 69:94–101. doi:10.1016/j.jaut.2016.03.005

    Article  PubMed  Google Scholar 

  215. Renauer P, Coit P, Sawalha AH (2016) Epigenetics and Vasculitis: a comprehensive review. Clin Rev Allergy Immunol 50(3):357–366. doi:10.1007/s12016-015-8495-6

    Article  CAS  PubMed  Google Scholar 

  216. Restuccia G, Boiardi L, Cavazza A, Catanoso M, Macchioni P, Muratore F, Soriano A, Cimino L, Aldigeri R, Crescentini F, Pipitone N, Salvarani C (2017) Long-term remission in biopsy proven giant cell arteritis: a retrospective cohort study. J Autoimmun 77:39–44. doi:10.1016/j.jaut.2016.10.002

    Article  PubMed  Google Scholar 

  217. Rizzo G, Licchetta L, Scaglione C, Buttiglione M, Capellari S, Martinelli P, Martino D (2016) Behcet disease presenting with movement disorders and antibasal ganglia antibodies. Autoimmun Rev 15(3):287–288. doi:10.1016/j.autrev.2015.11.011

    Article  PubMed  Google Scholar 

  218. Samson M, Ly KH, Tournier B, Janikashvili N, Trad M, Ciudad M, Gautheron A, Devilliers H, Quipourt V, Maurier F, Meaux-Ruault N, Magy-Bertrand N, Manckoundia P, Ornetti P, Maillefert JF, Besancenot JF, Ferrand C, Mesturoux L, Labrousse F, Fauchais AL, Saas P, Martin L, Audia S, Bonnotte B (2016) Involvement and prognosis value of CD8(+) T cells in giant cell arteritis. J Autoimmun 72:73–83. doi:10.1016/j.jaut.2016.05.008

    Article  CAS  PubMed  Google Scholar 

  219. Sawalha AH, Dozmorov MG (2016) Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis. J Autoimmun 67:76–81. doi:10.1016/j.jaut.2015.10.002

    Article  CAS  PubMed  Google Scholar 

  220. Weiner M, Segelmark M (2016) The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev 15(10):978–982. doi:10.1016/j.autrev.2016.07.016

    Article  CAS  PubMed  Google Scholar 

  221. Xue LJ, Wu R, Du GL, Xu Y, Yuan KY, Feng ZC, Pan YL, Hu GY (2017) Effect and safety of TNF inhibitors in immunoglobulin-resistant Kawasaki disease: a meta-analysis. Clin Rev Allergy Immunol 52(3):389–400. doi:10.1007/s12016-016-8581-4

    Article  CAS  PubMed  Google Scholar 

  222. Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Behcet’s disease: a comprehensive review. J Autoimmun 64:137–148. doi:10.1016/j.jaut.2015.08.013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  223. Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behcet N (2015) Efficacy of anti-TNF alpha in severe and/or refractory Behcet’s disease: multicenter study of 124 patients. J Autoimmun 62:67–74. doi:10.1016/j.jaut.2015.06.005

    Article  CAS  PubMed  Google Scholar 

  224. Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S (2015) Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: long-term follow up data of a randomized controlled multicentre study. J Autoimmun 63:88–93. doi:10.1016/j.jaut.2015.07.012

    Article  CAS  PubMed  Google Scholar 

  225. Bundhun PK, Soogund MZ, Huang F (2017) Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun 79:17–27. doi:10.1016/j.jaut.2017.02.009

    Article  PubMed  Google Scholar 

  226. Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG (2015) Treatment of rheumatoid arthritis: unraveling the conundrum. J Autoimmun 65:1–18. doi:10.1016/j.jaut.2015.10.003

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, via A. Manzoni 56, 20089, Rozzano, Milan, Italy

    Carlo Selmi

  2. Department of Medical Biotechnologies and Translational Medicine (BIOMETRA), University of Milan, Milan, Italy

    Carlo Selmi

Authors
  1. Carlo Selmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlo Selmi.

Ethics declarations

Conflict of Interest

The author declares that he has no conflict of interest.

Funding

No funding supported this paper.

Ethical Approval and Informed Consent

The present article is a review; thus, no informed consent was obtained.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selmi, C. Autoimmunity in 2016. Clinic Rev Allerg Immunol 53, 126–139 (2017). https://doi.org/10.1007/s12016-017-8615-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-017-8615-6

Keywords

Search

Navigation